Dopamine transporter density in schizophrenic subjects with and without tardive dyskinesia

被引:30
作者
Yoder, KK
Hutchins, GD
Morris, ED
Brashear, A
Wang, CZ
Shekhar, A
机构
[1] Res Inst 2, Dept Radiol, Div Res, Sect Imgaing Sci, Indianapolis, IN 46202 USA
[2] Indiana Univ Purdue Univ, Purdue Sch Engn & Technol, Indianapolis, IN USA
[3] Indiana Univ, Sch Med, Dept Neurol, Indianapolis, IN 46204 USA
[4] Indiana Univ, Sch Med, Dept Psychiat & Pharmacol, Indianapolis, IN 46204 USA
[5] Indiana Univ, Sch Med, Dept Toxicol, Indianapolis, IN 46204 USA
关键词
schizophrenia; FANSS; dopamine transporter; caudate; putamen; tardive dyskinesia;
D O I
10.1016/j.schres.2004.03.015
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Striatal dopamine transporter (DAT) binding potential (BP) was compared between schizophrenic subjects with and without tardive dyskinesia and controls. Although the groups were not statistically different in striatal BP, tardive subjects had apparently lower DAT density than non-tardive schizophrenic subjects. Significant and trend-level inverse correlations were found between DAT BP in the striatum, and especially the severity of negative symptom scores, but also cognitive, and depression/anxiety scores on the PANSS. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:371 / 375
页数:5
相关论文
共 50 条
  • [1] Dopamine transporter density in patients with tardive dyskinesia: a single photon emission computed tomography study
    Lavalaye, J
    Sarlet, A
    Booij, J
    Linszen, DH
    Reneman, L
    Gersons, BPR
    van Royen, EA
    PSYCHOPHARMACOLOGY, 2001, 155 (01) : 107 - 109
  • [2] SERUM-SOLUBLE INTERLEUKIN-2 RECEPTORS IN NEUROLEPTIC-NAIVE SCHIZOPHRENIC SUBJECTS AND IN MEDICATED SCHIZOPHRENIC SUBJECTS WITH AND WITHOUT TARDIVE-DYSKINESIA
    RAPAPORT, MH
    LOHR, JB
    ACTA PSYCHIATRICA SCANDINAVICA, 1994, 90 (05) : 311 - 315
  • [3] Dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients
    Garcia-Barceló, MM
    Lam, LCW
    Ungvari, GS
    Lam, VKL
    Tang, WK
    JOURNAL OF NEURAL TRANSMISSION, 2001, 108 (06) : 671 - 677
  • [4] Association of regulatory variants of dopamine β-hydroxylase with cognition and tardive dyskinesia in schizophrenia subjects
    Punchaichira, Toyanji J.
    Mukhopadhyay, Anirban
    Kukshal, Prachi
    Bhatia, Triptish
    Deshpande, Smita N.
    Thelma, B. K.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2020, 34 (03) : 358 - 369
  • [5] Clozapine efficacy in tardive dyskinesia in schizophrenic patients
    Bassitt, DP
    Neto, MRL
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 1998, 248 (04) : 209 - 211
  • [6] Serum vitamin B6 in schizophrenic and schizoaffective patients with and without tardive dyskinesia
    Miodownik, C
    Lerner, V
    Cohen, H
    Kotler, M
    CLINICAL NEUROPHARMACOLOGY, 2000, 23 (04) : 212 - 215
  • [7] Dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients
    M. M. Garcia-Barceló
    L. C. W. Lam
    G. S. Ungvari
    V. K. L. Lam
    W. K. Tang
    Journal of Neural Transmission, 2001, 108 : 671 - 677
  • [8] Signs of striatal dopamine transporter density increase in association with improvement of tardive dyskinesia in a patient with schizophrenia, as demonstrated by a DAT scan
    Rizos, E. N.
    Chatziioannou, S.
    Douzenis, A.
    Siafakas, N.
    Katsantoni, E.
    Nikolaidou, P.
    Papathanasiou, M.
    Lykouras, L.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 (02) : 132 - 136
  • [9] ASSESSMENT OF TARDIVE-DYSKINESIA IN SCHIZOPHRENIC OUTPATIENTS
    SMITH, JM
    KUCHARSKI, LT
    EBLEN, C
    KNUTSEN, E
    LINN, C
    PSYCHOPHARMACOLOGY, 1979, 64 (01) : 99 - 104
  • [10] Tardive Dyskinesia Exacerbated after Ingestion of Phenylalanine by Schizophrenic Patients
    Diane M Mosnik
    Bonnie Spring
    Keith Rogers
    Sankar Baruah
    Neuropsychopharmacology, 1997, 16 : 136 - 146